Maple Syrup Urine Disease

No abstract is available for this paper.

• Publication year

  1968

• Venue

  Proceedings of the Royal Society of Medicine

• Publication date

  1968-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/003591576806100335PMID 5645967PMCID PMC1902282
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dietary treatment of maple syrup urine disease.

  1967cited by this paper
• Dietary Treatment of a Child with Maple Syrup Urine Disease (Branched-chain Ketoaciduria)

  1963cited by this paper
• Maple Syrup Urine Disease

  1961cited by this paper
• Studies in Maple Syrup Urine Disease

  1961cited by this paper

• Metformin therapy to facilitate weight loss in adults with classic maple syrup urine disease.

  2026cites this paper
• The branched‐chain amino acid‐related isoleucic acid: recent research advances

  2025influential citation
• Single Amino Acid Supplementation in Inherited Metabolic Disorders: An Evidence-Based Review of Interventions

  2025cites this paper
• α-Ketoisocaproic Acid Disrupts Mitochondrial Bioenergetics in the Brain of Neonate Rats: Molecular Modeling Studies of α-ketoglutarate Dehydrogenase Subunits Inhibition

  2025cites this paper
• Pediatric liver transplant for maple syrup urine disease a single center experience

  2025cites this paper
• Advancing precision care in pregnancy through a treatable fetal findings list.

  2025cites this paper
• Adenine base editing rescues disrupted BCKDH function and reduces BCAAs toxic accumulation in maple syrup urine disease patient iPSC-hepatic organoids

  2025influential citation
• Thiamine-responsive maple syrup urine disease missed by newborn screen: A case report

  2025cites this paper
• Update on glycogen storage disease: a brief review of the main disorders.

  2025cites this paper
• Application of high-resolution mass spectrometry profiling towards the diagnosis and acute management of maple syrup urine disease

  2025cites this paper
• Acute liver failure caused by amino acid or organic acid related inborn errors of metabolism.

  2025cites this paper
• Daytime-Dependent Effects of Thiamine on the Thiamine Pool and Pyruvate Dehydrogenase Regulation in the Brain and Heart

  2025cites this paper
• Branched Chain Amino Acid Metabolism in Developmental Brain Injury: Putative Mechanisms and Therapeutic Potential

  2025cites this paper
• Mechanisms and Therapeutic Potential of Key Anti-inflammatory Metabiotics: Trans-Vaccenic Acid, Indole-3-Lactic Acid, Thiamine, and Butyric Acid

  2025cites this paper
• Nutrition Support Therapy for Hospitalized Children with Malnutrition: A Narrative Review

  2025influential citation
• Acute encephalopathy in a neonate: a diagnostic odyssey leading to maple syrup urine disease (MSUD)

  2025cites this paper
• The oral phenotype and dental management in patients with maple syrup urine disease; case report and scoping review

  2024influential citation
• Primary Roles of Branched Chain Amino Acids (BCAAs) and Their Metabolism in Physiology and Metabolic Disorders

  2024cites this paper
• Transcriptomic analysis identifies the shared diagnostic biomarkers and immune relationship between Atherosclerosis and abdominal aortic aneurysm based on fatty acid metabolism gene set

  2024cites this paper
• Review : Maple Syrup Urine Disease : A Rare Inherted Disorder of Amino Acid Metabolism

  2024influential citation
• The Impact of Diet on Body Composition in a Cohort of Pediatric and Adult Patients with Maple Syrup Urine Disease

  2024cites this paper
• Maple syrup urine disease diagnosed in a resource-limited setting in an infant in Nepal: a case report

  2024cites this paper
• Assembly of branched chain amino acid (BCAA) to toxic fibrils may be related to pathogenesis of Maple syrup urine disease (MSUD)

  2024cites this paper
• Exploring molecular spectrum in thai patients with maple syrup urine disease: unveiling a common variant

  2024influential citation
• The interplay of psychosis and non‐compliance with fatal outcome in an adult with MSUD

  2024cites this paper
• Une ataxie récidivante

  2024cites this paper
• Domino Liver Transplantation: Anesthetic Considerations for a Patient With Maple Syrup Urine Disease and Type I Diabetes Mellitus

  2024cites this paper
• Computational structural genomics and clinical evidence suggest BCKDK gain‐of‐function may cause a potentially asymptomatic maple syrup urine disease phenotype

  2024cites this paper
• Successful treatment of severe MSUD in Bckdhb−/− mice with neonatal AAV gene therapy

  2023cites this paper
• Identification of gene mutations in six Chinese patients with maple syrup urine disease

  2023cites this paper
• Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic Disorders

  2023cites this paper
• Definition of the Neurotoxicity-Associated Metabolic Signature Triggered by Berberine and Other Respiratory Chain Inhibitors

  2023cites this paper
• N-Acetylglutamate and N-acetylmethionine compromise mitochondrial bioenergetics homeostasis and glutamate oxidation in brain of developing rats: Potential implications for the pathogenesis of ACY1 deficiency.

  2023cites this paper
• Acute Encephalopathy Caused by Inherited Metabolic Diseases

  2023cites this paper
• Outcomes from a Single Transplant Center of 5 Pediatric Cases of Domino Liver Transplantation from Live Donors with Maple Syrup Urine Disease

  2023cites this paper
• In Vivo Intracerebral Administration of α-Ketoisocaproic Acid to Neonate Rats Disrupts Brain Redox Homeostasis and Promotes Neuronal Death, Glial Reactivity, and Myelination Injury

  2023cites this paper
• Newborn screening of maple syrup urine disease and the effect of early diagnosis.

  2023cites this paper
• Treatment of maple syrup urine disease: Benefits, risks, and challenges of liver transplantation

  2023cites this paper
• Organic Aciduria Disorders in Pregnancy: An Overview of Metabolic Considerations

  2023cites this paper
• PPM1K defects cause mild maple syrup urine disease: The second case in the literature

  2023influential citation
• Maple Syrup Urine Disease: An Uncommon Cause of Neonatal Febrile Seizures

  2023cites this paper
• Knowledge-Based Dietary Intake Recommendations of Nutrients for Pediatric Patients with Maple Syrup Urine Disease

  2023cites this paper
• Oral enzyme therapy for maple syrup urine disease (MSUD) suppresses plasma leucine levels in intermediate MSUD mice and healthy nonhuman primates

  2023cites this paper
• BCAA–BCKA axis regulates WAT browning through acetylation of PRDM16

  2022cites this paper
• A Gain-of-Function Mutation on BCKDK Gene and Its Possible Pathogenic Role in Branched-Chain Amino Acid Metabolism

  2022cites this paper
• Neonatal Screening

  2022cites this paper
• Neuroimaging in cerebellar ataxia in childhood: A review

  2022cites this paper
• A novel mutation in the DBT gene causes in an Azerbaijanian child classic maple syrup urine disease

  2022cites this paper
• Intravenous branched-chain amino-acid-free solution for the treatment of metabolic decompensation episodes in Spanish pediatric patients with maple syrup urine disease

  2022cites this paper
• Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes

  2022cites this paper
• An approach to recognising and identifying metabolic presentations in the paediatric Irish Traveller population

  2022cites this paper
• Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study

  2022cites this paper
• Organic Acidemias.

  2022cites this paper
• Genomic and biochemical analysis of repeatedly observed variants in DBT in individuals with maple syrup urine disease of Central American ancestry

  2022cites this paper
• Novel Missense Variation in NDUFA9 Gene in an Iranian Patient with Fatal Leigh Syndrome

  2022cites this paper
• Neonatal maple syrup urine disease case report and literature review

  2022cites this paper
• Pathophysiology of maple syrup urine disease: Focus on the neurotoxic role of the accumulated branched-chain amino acids and branched-chain α-keto acids.

  2022cites this paper
• Branched-chain amino acids (BCAA) administration increases autophagy and the autophagic pathway in brain tissue of rats submitted to a Maple Syrup Urine Disease (MSUD) protocol

  2022cites this paper
• Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders

  2022cites this paper
• Maple syrup urine disease due to a paracentric inversion of chr 19 that disrupts BCKDHA : A case report

  2022cites this paper
• Coadministration of tianeptine alters behavioral parameters and levels of neurotrophins in a chronic model of Maple Syrup Urine disease

  2022cites this paper
• Kentucky Anabaptists' Knowledge of Newborn Screening

  2022cites this paper
• Genome-wide association study of brain arteriolosclerosis

  2022cites this paper
• Maple syrup urine disease decompensation misdiagnosed as a psychotic event

  2022cites this paper
• Continuous veno‐venous hemodiafiltration in neonates with maple syrup urine disease

  2022influential citation
• Case report: NAFLD and maple syrup urine disease: Is there an interplay between branched-chain amino acids and fructose consumption?

  2022cites this paper
• Orthopaedic Problems in 35 Patients With Organic Acid Disorders

  2021cites this paper
• Hyperleucinosis during infections in maple syrup urine disease post liver transplantation

  2021influential citation
• Challenges in Diagnosing Intermediate Maple Syrup Urine Disease by Newborn Screening and Functional Validation of Genomic Results Imperative for Reproductive Family Planning

  2021cites this paper
• Metabolic Seizures

  2021influential citation
• Diagnosis of Genetic and Metabolic Conditions

  2021cites this paper
• Clinical perspective on the use of human amniotic epithelial cells to treat congenital metabolic diseases with a focus on maple syrup urine disease

  2021cites this paper
• Maple syrup urine disease: Characteristics of diagnosis and treatment in 45 patients in Chile

  2021influential citation
• REVIEW: Practical strategies to maintain anabolism by intravenous nutritional management in children with inborn metabolic diseases.

  2021cites this paper
• Comparison of The Peritoneal Dialysis and Continuous Veno-Venous Hemodiafiltration in 16 Neonates With Maple Syrup Urine Disease

  2021influential citation
• Effects of B-Group Vitamin Administration on Daily Change in Urine 2-Oxo Acids in Young Japanese Women.

  2021cites this paper
• Use of Molecular Genetic Analyses in Danish Routine Newborn Screening

  2021cites this paper
• Brain magnetic resonance imaging findings and radiologic review of maple syrup urine disease: Report of three cases

  2021cites this paper
• Maple syrup urine disease associated with nephrotic syndrome in a Filipino child

  2021cites this paper
• ADHD symptoms in neurometabolic diseases: Underlying mechanisms and clinical implications.

  2021cites this paper
• Domino transplantation for pediatric liver recipients: Obstacles, challenges, and successes

  2021cites this paper
• Molecular basis of various forms of maple syrup urine disease in Chilean patients

  2021influential citation
• Neonatal Metabolic Crises: A Practical Approach.

  2020cites this paper
• Identification of Four Novel Mutations in Chilean Patients with Various Forms of Maple Syrup Urine Disease 

  2020influential citation
• Maple syrup urine disease presenting as severe neonatal metabolic encephalopathy: a case report

  2020cites this paper
• Branched-chain alpha-ketoacid dehydrogenase deficiency (maple Branched-chain alpha-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes syrup urine disease): Treatment, biomarkers, and outcomes us how to this you.

  2020influential citation
• Crigler‐Najjar Syndrome Type 1: Pathophysiology, Natural History, and Therapeutic Frontier

  2020cites this paper
• Hereditary characteristics of the S339L mutation in a patient with maple syrup urine disease in Vietnam

  2020cites this paper
• Diagnosis of inherited metabolic disorders by selective metabolite testing: three years' experience at a tertiary care center in Rawalpindi.

  2020cites this paper
• Evaluation of 11 years of newborn screening for maple syrup urine disease in the Netherlands and a systematic review of the literature: Strategies for optimization

  2020cites this paper
• Growth hormone as a rescue treatment in maple syrup urine disease with lessons from pediatric burn literature, case report and brief literature review

  2020cites this paper
• Metformin extends the lifespan of iMSUD mice by rescuing physiologic dysfunction and modulating mechanisms of mTORC1 activation

  2020cites this paper
• Clinical Child Neurology

  2020influential citation
• Inherited Metabolic Disorders Presenting with Ataxia

  2020influential citation
• Impact of sodium phenylbutyrate treatment in acute management of maple syrup urine disease attacks: a single-center experience

  2020cites this paper
• 3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients

  2020cites this paper
• Amino Acids | Branched-Chain Amino Metabolism

  2020cites this paper
• Reporte de caso y revisión de literatura: Enfermedad de orina con olor a jarabe de arce

  2020cites this paper
• Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders

  2020cites this paper
• Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.

  2020influential citation